Context Therapeutics (CNTX) Stock Price & Financial Analysis
Context Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Context Therapeutics
What is the current stock price for CNTX?
As of the latest trading session, CNTX stock trades at $2.72. The 52-week range is $0.49–$3.62, with a day range of $2.56–$2.96.
What is the P/E ratio for CNTX?
The P/E ratio (Price-to-Earnings) for CNTX is shown in the Key Statistics section. This valuation metric helps compare Context Therapeutics Inc. to industry peers.
Does CNTX pay dividends?
Context Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CNTX?
Based on 3 analysts, the consensus for CNTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CNTX?
Context Therapeutics's market capitalization is $258.9M, classifying it as a micro-cap company. Context Therapeutics operates in the Healthcare sector within the Biotechnology industry.